Cargando…

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity

Detalles Bibliográficos
Autores principales: Shah, Parag K, Morris, Rodney J, Narendran, V, Kalpana, N
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032257/
https://www.ncbi.nlm.nih.gov/pubmed/21157086
http://dx.doi.org/10.4103/0301-4738.73707
_version_ 1782197438638981120
author Shah, Parag K
Morris, Rodney J
Narendran, V
Kalpana, N
author_facet Shah, Parag K
Morris, Rodney J
Narendran, V
Kalpana, N
author_sort Shah, Parag K
collection PubMed
description
format Text
id pubmed-3032257
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30322572011-02-09 Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity Shah, Parag K Morris, Rodney J Narendran, V Kalpana, N Indian J Ophthalmol Letters to Editor Medknow Publications 2011 /pmc/articles/PMC3032257/ /pubmed/21157086 http://dx.doi.org/10.4103/0301-4738.73707 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to Editor
Shah, Parag K
Morris, Rodney J
Narendran, V
Kalpana, N
Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title_full Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title_fullStr Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title_full_unstemmed Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title_short Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
title_sort visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (avastin) in aggressive posterior retinopathy of prematurity
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032257/
https://www.ncbi.nlm.nih.gov/pubmed/21157086
http://dx.doi.org/10.4103/0301-4738.73707
work_keys_str_mv AT shahparagk visualacuityandelectroretinographyfindings31⁄2yearsafterthefirstintravitrealinjectionofbevacizumabavastininaggressiveposteriorretinopathyofprematurity
AT morrisrodneyj visualacuityandelectroretinographyfindings31⁄2yearsafterthefirstintravitrealinjectionofbevacizumabavastininaggressiveposteriorretinopathyofprematurity
AT narendranv visualacuityandelectroretinographyfindings31⁄2yearsafterthefirstintravitrealinjectionofbevacizumabavastininaggressiveposteriorretinopathyofprematurity
AT kalpanan visualacuityandelectroretinographyfindings31⁄2yearsafterthefirstintravitrealinjectionofbevacizumabavastininaggressiveposteriorretinopathyofprematurity